✦ LIBER ✦

Meta-analysis of concomitant compared to sequential adjuvant trastuzumab in breast cancer: the sooner the better

✍ Scribed by Fausto Petrelli, Sandro Barni

Book ID: 113093664
Publisher: Springer US
Year: 2011
Tongue: English
Weight: 242 KB
Volume: 29
Category: Article
ISSN: 1357-0560
DOI: 10.1007/s12032-011-9897-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness analysis of trastuzum

Cost-effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2-positive breast cancer

✍ Louis P. Garrison Jr; Deborah Lubeck; Deepa Lalla; Virginia Paton; Amylou Dueck; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 2 views

## Abstract ## BACKGROUND. Adding trastuzumab to adjuvant chemotherapy provides significant clinical benefit in patients with human epidermal growth factor receptor 2 (HER2)‐positive breast cancer. A cost‐effectiveness analysis was performed to assess clinical and economic implications of adding t

Adjuvant chemotherapy plus tamoxifen com

Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: meta-analysis of quality-adjusted survival

✍ R.D. Gelber; B.F. Cole; A. Goldhirsch; C. Rose; B. Fisher; C.K. Osborne; F. Bocc 📂 Article 📅 1996 🏛 The Lancet 🌐 English ⚖ 797 KB

Lapatinib, trastuzumab or the combinatio

Lapatinib, trastuzumab or the combination added to preoperative chemotherapy for breast cancer: a meta-analysis of randomized evidence

✍ Antonis Valachis, Andreas Nearchou, Pehr Lind, Davide Mauri 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 354 KB

The Cost-Utility of Sequential Adjuvant

The Cost-Utility of Sequential Adjuvant Trastuzumab in Women with Her2/Neu-Positive Breast Cancer: An Analysis Based On Updated Results from the HERA Trial

✍ Chris Skedgel; Daniel Rayson; Tallal Younis 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB

Cardiotoxicity and incidence of brain me

Cardiotoxicity and incidence of brain metastases after adjuvant trastuzumab for early breast cancer: the dark side of the moon? A meta-analysis of the randomized trials

✍ Emilio Bria; Federica Cuppone; Monica Fornier; Cecilia Nisticò; Paolo Carlini; M 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 289 KB

The role of chemoendocrine agents in pos

The role of chemoendocrine agents in postoperative adjuvant therapy for breast cancer: Meta-analysis of the first collaborative studies of postoperative adjuvant chemoendocrine therapy for breast cancer (ACETBC)

✍ Osahiko Abe 📂 Article 📅 1994 🏛 Springer Japan 🌐 English ⚖ 605 KB